Holders over time
- NTRA
- TMO
| Quarter | NTRA | TMO |
|---|---|---|
| Q4 2020 | 15 holders, $741m | 33 holders, $39.2bn |
| Q1 2021 | 17 holders, $911m | 35 holders, $36.5bn |
| Q2 2021 | 20 holders, $1.4bn | 33 holders, $38.3bn |
| Q3 2021 | 17 holders, $1.3bn | 32 holders, $42.6bn |
| Q4 2021 | 14 holders, $1.2bn | 38 holders, $50.1bn |
| Q1 2022 | 13 holders, $551m | 32 holders, $43.2bn |
| Q2 2022 | 14 holders, $473m | 33 holders, $38.9bn |
| Q3 2022 | 10 holders, $365m | 26 holders, $34.3bn |
| Q4 2022 | 12 holders, $266m | 29 holders, $37.0bn |
| Q1 2023 | 14 holders, $658m | 35 holders, $37.1bn |
| Q2 2023 | 10 holders, $474m | 39 holders, $33.5bn |
| Q3 2023 | 10 holders, $554m | 39 holders, $32.6bn |
| Q4 2023 | 12 holders, $695m | 41 holders, $32.7bn |
| Q1 2024 | 18 holders, $2.0bn | 30 holders, $34.1bn |
| Q2 2024 | 22 holders, $2.5bn | 38 holders, $30.6bn |
| Q3 2024 | 25 holders, $3.6bn | 30 holders, $33.8bn |
| Q4 2024 | 28 holders, $4.5bn | 36 holders, $27.6bn |
| Q1 2025 | 21 holders, $4.6bn | 31 holders, $24.2bn |
| Q2 2025 | 21 holders, $5.4bn | 39 holders, $18.8bn |
| Q3 2025 | 23 holders, $4.8bn | 32 holders, $21.9bn |
| Q4 2025 | 26 holders, $8.1bn | 32 holders, $29.9bn |
| Q1 2026 | 20 holders, $6.7bn | 34 holders, $24.4bn |
| Q2 2026 | 23 holders, $10.0bn | 36 holders, $26.4bn |
| Q3 2026 | 22 holders, $16.9bn | 35 holders, $40.3bn |
Natera Inc
- Holders
- 21
- Reported value
- $5.4bn
- Buyers
- 12
- Sellers
- 9
Breadth +3 among 95 comparable managers.
Thermo Fisher Scientific Inc
- Holders
- 39
- Reported value
- $18.8bn
- Buyers
- 27
- Sellers
- 11
Breadth +16 among 95 comparable managers.
Who holds both, Q2 2025
Both (15)
Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Capital World Investors, Farallon Capital Management LLC, Invesco Ltd, MFS Investment Management, Point72 Asset Management LP, Polen Capital Management LLC, Renaissance Technologies LLC, Rokos Capital Management LLP, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP, Wellington Management Group LLP
Only NTRA (6)
AQR Capital Management LLC, ARK Investment Management LLC, Freestone Grove Partners LP, Holocene Advisors LP, Maverick Capital Ltd, PDT Partners LLC
Only TMO (24)
AllianceBernstein LP, Baillie Gifford & Co, Brevan Howard Capital Management LP, Capital Research Global Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Glenview Capital Management LLC, Jane Street Group LLC, Janus Henderson Group Ltd, Markel Group Inc, Marshall Wace LLP, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Tudor Investment Corp, Verition Fund Management LLC, Voloridge Investment Management LLC, Winton Group Ltd
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.